Vanderbilt technologies earns U.S. patent protection in August

One Vanderbilt technology earned U.S. patent protection in August. The set of compounds earning protection were developed by a team of researchers in the Vanderbilt Center for Neuroscience Drug Discovery

8,796,295 Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same.